Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patients with cytomegalovirus retinitis

John C. Canzano, John B. Reed, Lawrence S Morse

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Purpose: To report the development of vitreomacular traction syndrome (VMT) following highly active antiretroviral therapy (HAART) in AIDS patients with cytomegalovirus retinitis (CMV-R). Methods: We identified two AIDS patients with evidence of CMV-R who later developed VMT following HAART- associated immune recovery vitritis. Results: The CD4+ T-lymphocyte count increased from 5 to 190 cells/μL in Patient 1 and from 26 to 713 cells/μL in Patient 2. HIV-RNA copies/mL decreased from 341,000 to less than 400 in Patient 1 and from 43,900 to less than 400 in Patient 2. Increased vitreous inflammation occurred during this period of immune recovery. After resolution of vitritis, VMT developed in both patients and was confirmed by B-scan ultrasound and fluorescein angiography. In both patients, CMV-R was clinically inactive at the time of VMT development. Both patients underwent pars plana vitrectomy with peeling of the posterior hyaloid, which confirmed VMT intraoperatively. Conclusions: VMT appears to be a sequelae of HAART- associated immune recovery vitritis in AIDS-related CMV-R. Changes in immune status may permit an inflammatory response that can lead to VMT. As advances in pharmacologic intervention continue, clinical manifestations and ocular sequelae in CMV-R will change, as will the approach and management of this disease.

Original languageEnglish (US)
Pages (from-to)443-447
Number of pages5
JournalRetina
Volume18
Issue number5
StatePublished - 1998

Fingerprint

Cytomegalovirus Retinitis
Highly Active Antiretroviral Therapy
Traction
Acquired Immunodeficiency Syndrome
Temazepam
Fluorescein Angiography
Vitrectomy
CD4 Lymphocyte Count
Disease Management
HIV
RNA
Inflammation
T-Lymphocytes

Keywords

  • Cytomegalovirus retinitis
  • Highly active antiretroviral therapy
  • Protease inhibitors
  • Vitreomacular traction syndrome

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patients with cytomegalovirus retinitis. / Canzano, John C.; Reed, John B.; Morse, Lawrence S.

In: Retina, Vol. 18, No. 5, 1998, p. 443-447.

Research output: Contribution to journalArticle

@article{49df3113b10d413ab9df7fc5189e2f35,
title = "Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patients with cytomegalovirus retinitis",
abstract = "Purpose: To report the development of vitreomacular traction syndrome (VMT) following highly active antiretroviral therapy (HAART) in AIDS patients with cytomegalovirus retinitis (CMV-R). Methods: We identified two AIDS patients with evidence of CMV-R who later developed VMT following HAART- associated immune recovery vitritis. Results: The CD4+ T-lymphocyte count increased from 5 to 190 cells/μL in Patient 1 and from 26 to 713 cells/μL in Patient 2. HIV-RNA copies/mL decreased from 341,000 to less than 400 in Patient 1 and from 43,900 to less than 400 in Patient 2. Increased vitreous inflammation occurred during this period of immune recovery. After resolution of vitritis, VMT developed in both patients and was confirmed by B-scan ultrasound and fluorescein angiography. In both patients, CMV-R was clinically inactive at the time of VMT development. Both patients underwent pars plana vitrectomy with peeling of the posterior hyaloid, which confirmed VMT intraoperatively. Conclusions: VMT appears to be a sequelae of HAART- associated immune recovery vitritis in AIDS-related CMV-R. Changes in immune status may permit an inflammatory response that can lead to VMT. As advances in pharmacologic intervention continue, clinical manifestations and ocular sequelae in CMV-R will change, as will the approach and management of this disease.",
keywords = "Cytomegalovirus retinitis, Highly active antiretroviral therapy, Protease inhibitors, Vitreomacular traction syndrome",
author = "Canzano, {John C.} and Reed, {John B.} and Morse, {Lawrence S}",
year = "1998",
language = "English (US)",
volume = "18",
pages = "443--447",
journal = "Retina",
issn = "0275-004X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patients with cytomegalovirus retinitis

AU - Canzano, John C.

AU - Reed, John B.

AU - Morse, Lawrence S

PY - 1998

Y1 - 1998

N2 - Purpose: To report the development of vitreomacular traction syndrome (VMT) following highly active antiretroviral therapy (HAART) in AIDS patients with cytomegalovirus retinitis (CMV-R). Methods: We identified two AIDS patients with evidence of CMV-R who later developed VMT following HAART- associated immune recovery vitritis. Results: The CD4+ T-lymphocyte count increased from 5 to 190 cells/μL in Patient 1 and from 26 to 713 cells/μL in Patient 2. HIV-RNA copies/mL decreased from 341,000 to less than 400 in Patient 1 and from 43,900 to less than 400 in Patient 2. Increased vitreous inflammation occurred during this period of immune recovery. After resolution of vitritis, VMT developed in both patients and was confirmed by B-scan ultrasound and fluorescein angiography. In both patients, CMV-R was clinically inactive at the time of VMT development. Both patients underwent pars plana vitrectomy with peeling of the posterior hyaloid, which confirmed VMT intraoperatively. Conclusions: VMT appears to be a sequelae of HAART- associated immune recovery vitritis in AIDS-related CMV-R. Changes in immune status may permit an inflammatory response that can lead to VMT. As advances in pharmacologic intervention continue, clinical manifestations and ocular sequelae in CMV-R will change, as will the approach and management of this disease.

AB - Purpose: To report the development of vitreomacular traction syndrome (VMT) following highly active antiretroviral therapy (HAART) in AIDS patients with cytomegalovirus retinitis (CMV-R). Methods: We identified two AIDS patients with evidence of CMV-R who later developed VMT following HAART- associated immune recovery vitritis. Results: The CD4+ T-lymphocyte count increased from 5 to 190 cells/μL in Patient 1 and from 26 to 713 cells/μL in Patient 2. HIV-RNA copies/mL decreased from 341,000 to less than 400 in Patient 1 and from 43,900 to less than 400 in Patient 2. Increased vitreous inflammation occurred during this period of immune recovery. After resolution of vitritis, VMT developed in both patients and was confirmed by B-scan ultrasound and fluorescein angiography. In both patients, CMV-R was clinically inactive at the time of VMT development. Both patients underwent pars plana vitrectomy with peeling of the posterior hyaloid, which confirmed VMT intraoperatively. Conclusions: VMT appears to be a sequelae of HAART- associated immune recovery vitritis in AIDS-related CMV-R. Changes in immune status may permit an inflammatory response that can lead to VMT. As advances in pharmacologic intervention continue, clinical manifestations and ocular sequelae in CMV-R will change, as will the approach and management of this disease.

KW - Cytomegalovirus retinitis

KW - Highly active antiretroviral therapy

KW - Protease inhibitors

KW - Vitreomacular traction syndrome

UR - http://www.scopus.com/inward/record.url?scp=0032470779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032470779&partnerID=8YFLogxK

M3 - Article

C2 - 9801041

AN - SCOPUS:0032470779

VL - 18

SP - 443

EP - 447

JO - Retina

JF - Retina

SN - 0275-004X

IS - 5

ER -